These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26558635)

  • 41. The painful purple digit: an alarming complication of Candida albicans antigen treatment of recalcitrant warts.
    Perman M; Sterling JB; Gaspari A
    Dermatitis; 2005 Mar; 16(1):38-40. PubMed ID: 15996350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of serum interleukin 17 and macrophage migration inhibitory factor levels with clinical response to intralesional Candida antigen and their potential use as predictors of clinical outcome in patients with multiple common warts.
    Nassar A; Nofal A; Bakr NM; Essam R; Alakad R
    J Cosmet Dermatol; 2022 Sep; 21(9):3970-3978. PubMed ID: 34964227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of varicella zoster vaccine vs candida antigen injection in treatment of warts.
    Amer A; Nassar A; Gamal D; Marei A
    Dermatol Ther; 2021 Jan; 34(1):e14667. PubMed ID: 33314490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative clinico-dermoscopic study of intralesional injection of combined digoxin and furosemide, Candida antigen, and vitamin D3 for multiple warts.
    Nasr M; Abdelaty S; Elkholy BM
    J Cosmet Dermatol; 2023 Apr; 22(4):1344-1353. PubMed ID: 36606379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined oral isotretinoin and Candida antigen versus either agent alone in the treatment of plane warts.
    Nofal A; Khedr A; Fathy M
    J Dermatolog Treat; 2022 Feb; 33(1):342-347. PubMed ID: 32271637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of tuberculin immunotherapy in verruca vulgaris: Our experience from single center from North-West India and review of literature.
    Gogia P; Thami GP; Poonia K; Bhalla M; Garg G
    Dermatol Ther; 2021 Mar; 34(2):e14843. PubMed ID: 33528095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy-resistant warts.
    Kaimal S; Gopinath H; Premalatha V
    Int J Dermatol; 2020 Jun; 59(6):726-729. PubMed ID: 32112396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
    Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
    J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts.
    Na CH; Choi H; Song SH; Kim MS; Shin BS
    Clin Exp Dermatol; 2014 Jul; 39(5):583-9. PubMed ID: 24934912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of single versus multiple intralesional immunotherapy with purified protein derivative (PPD) in the treatment of multiple verruca vulgaris.
    Milante RR; Venida-Tablizo A; King-Ismael D
    Int J Dermatol; 2019 Dec; 58(12):1477-1482. PubMed ID: 31591706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Candida immunotherapy of warts.
    Signore RJ
    Arch Dermatol; 2001 Sep; 137(9):1250-1. PubMed ID: 11559230
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study.
    Majid I; Imran S
    Indian J Dermatol; 2013 Sep; 58(5):360-5. PubMed ID: 24082180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study.
    Nofal A; Albalat W; Ismail A; Khattab FM
    J Dermatolog Treat; 2022 Mar; 33(2):922-927. PubMed ID: 32609022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of recalcitrant molluscum contagiosum in a stem cell transplant patient with Candida immunotherapy.
    Thomas RM; Gillihan R; Longo M
    Dermatol Ther; 2019 Sep; 32(5):e12999. PubMed ID: 31222883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The status of immunotherapy in the United States, 2002.
    Silverberg NB
    Cutis; 2002 Sep; 70(3):155-6. PubMed ID: 12353888
    [No Abstract]   [Full Text] [Related]  

  • 57. Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis.
    Ju HJ; Park HR; Kim JY; Kim GM; Bae JM; Lee JH
    Indian J Dermatol Venereol Leprol; 2022; 88(6):724-737. PubMed ID: 35962514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effectiveness of intralesional Candida antigen immunotherapy as a treatment for anogenital warts: a retrospective chart review.
    Logel M; Pammett R; Chiang C; O'Toole A; Gooderham M
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e142-e145. PubMed ID: 34553430
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative efficacy of intralesional Candida antigen, intralesional bivalent human papilloma virus vaccine, and cryotherapy in the treatment of common warts.
    Nassar A; Alakad R; Essam R; Bakr NM; Nofal A
    J Am Acad Dermatol; 2022 Aug; 87(2):419-421. PubMed ID: 34464624
    [No Abstract]   [Full Text] [Related]  

  • 60. Intralesional Vitamin D
    Raghukumar S; Ravikumar BC; Vinay KN; Suresh MR; Aggarwal A; Yashovardhana DP
    J Cutan Med Surg; 2017; 21(4):320-324. PubMed ID: 28384048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.